Taiwanese Journal of Obstetrics and Gynecology
Volume 47, Issue 3 , Pages 322-326 , September 2008

Salvage Chemotherapy in Recurrent Cervical Cancer With Biweekly Pegylated Liposomal Doxorubicin (Lipo-Dox)

  • Jen-Ruei Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • ,
  • Yuh-Cheng Yang

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • Taipei Medical University, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
    • ,
  • Tze-Chien Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • ,
  • Jerry Cheng-Yen Lai

      Affiliations

    • Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
    • ,
  • Shing-Jyh Chang

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • National Tsing Hua University, Hsinchu, Taipei, Taiwan
    • ,
  • Chi-Long Chang

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • ,
  • Kung-Liahng Wang

      Affiliations

    • Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
    • National Taipei College of Nursing, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Kung-Liahng Wang, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Mackay Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan

,Accepted 23 January 2008.

References 

  1. Bosch FX , Manos MM , Munoz N , et al.   Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group . J Natl Cancer Inst . 1995;87:796–802
  2. Chen HS , Yang YC , Su TH , Wang TY , Huang YW . Human papillomavirus testing (hybrid capture II) to detect highgrade cervical intraepithelial neoplasia in women with mildly abnormal papanicolaou results . Taiwan J Obstet Gynecol . 2005;44:252–257
  3. Cheng WF . Human papillomavirus vaccine for cervical cancer: where are we now? . Taiwan J Obstet Gynecol . 2005;44:232–241
  4. Wang PD , Lin RS . Epidemiology of cervical cancer in Taiwan . Gynecol Oncol . 1996;62:344–352
  5. Bureau of Health Promotion  . Department of Health, Taiwan. November 16, 2006 . Available at: http://www.bhp.doh.gov.tw/asp/themeParkId=510/960305/pdf/951116.pdf [Date accessed: March 22, 2007]
  6. Tseng CC , Tseng CJ , Chang CC , et al.   Human papillomavirus deoxyribonucleic acid sequences and clinical outcomes of cervical cancer patients following radiotherapy . Taiwan J Obstet Gynecol . 2004;43:20–24
  7. Tambaro R, Scambia G, Di Maio M, Pisano C, Barletta E, Iaffaioli VR, et al. The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer . Crit Rev Oncol Hematol . 2004;52:33–44
  8. Lasic DD . Doxorubicin in sterically stabilized liposomes . Nature . 1996;380:561–562
  9. Verschraegen CF , Kavanagh JJ , Loyer E , et al. , Community Clinical Oncology Program    Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix . Cancer . 2001;92:2327–2333
  10. O'Byrne KJ , Bliss P , Graham JD , et al.   A phase III study of Doxil/Caelyx versus paclitaxel in platinum-treated, taxanenaive relapsed ovarian cancer . Proc Am Soc Clin Oncol . 2002;21:203a; [Abstract 808]
  11. Gordon AN , Fleagle JT , Guthrie D , Parkin DE , Gore ME , Lacave AJ . Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan . J Clin Oncol . 2001;19:3312–3322
  12. Gordon AN , Tonda M , Sun S , Rackoff W , Doxil Study 30–49 Investigators  . Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer . Gynecol Oncol . 2004;95:1–8
  13. Woll PJ, Carmichael J, Chan S, Howell A, Ranson M, Miles D, et al. Phase II study results on safety and tolerability of Caelyx® (Doxil®) in combination with paclitaxel in the treatment of metastatic breast cancer . Proc Am Soc Clin Oncol . 1999;18:117a; [Abstract 442]
  14. Harrison M , Tomlinson D , Stewart S . Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma . J Clin Oncol . 1995;13:914–920
  15. Chou HH , Wang KL , Chen CA , et al. , Taiwanese Gynecologic Oncology Group    Pegylated liposomal doxorubicin (Lipo-Dox) for platinum-resistant or refractory epithelial ovarian carcinoma: a Taiwanese gynecologic oncology group study with long-term follow-up . Gynecol Oncol . 2006;101:423–428
  16. Lorusso D , Naldini A , Testa A , D'Agostino G , Scambia G , Ferrandina G . Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients . Oncology . 2004;67:243–249
  17. Martin FJ , Gabizon A , et al.   Human pharmacokinetics of stealth liposomes containing doxorubicin . J Cell Biochem . 1992;50(Suppl 16E):98
  18. Gabizon A . Liposomal anthracyclines . Hematol Oncol Clin North Am . 1994;8:431–450
  19. Ferrandina G , Lorusso D , Longo R , Testa AC , Scambia G . Pegylated liposomal doxorubicin in platinum-treated recurrent or metastatic cervical carcinoma . Gynecol Oncol . 2005;98:332–333
  20. Rose PG , Blessing JA , Lele S , Abulafia O . Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group . Gynecol Oncol . 2006;102:210–213

PII: S1028-4559(08)60132-1

doi: 10.1016/S1028-4559(08)60132-1

Taiwanese Journal of Obstetrics and Gynecology
Volume 47, Issue 3 , Pages 322-326 , September 2008

Article Tools